ENDOTHELIN - POTENTIAL ROLE IN DEVELOPMENT AND DISEASE

被引：6

作者：

KON, V

FOGO, A

机构：

[1] Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, 37232-2584, Tennessee

[2] Department of Pathology, Vanderbilt University School of Medicine, Nashville, 37232-2584, Tennessee

来源：

PEDIATRIC NEPHROLOGY | 1993年 / 7卷 / 06期

关键词：

ENDOTHELIN; VASOCONSTRICTION; DEVELOPMENT; GROWTH;

D O I：

10.1007/BF01213377

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Endothelin is a vasoconstrictor substance, initially isolated from porcine endothelial cell supernatant, which has a structure different from any other mammalian peptide. An extensive array of biological activities has been ascribed to endothelin which, besides having unrivaled vasoconstrictive effects, modulates neurotransmission, regulates other hormones and neurotransmitters, and also has potent hyperplastic/hypertrophic effects. These observations have suggested important roles for endothelin in pathophysiological conditions and also in normal development. Inhibition of endothelin activity can decrease vasoconstriction associated with pathophysiological settings. Inhibition of endothelin activity also decreases mitogenesis and therefore cellular proliferation and growth, thereby supporting a role for endothelin in processes which are an integral part of normal development.

引用

页码：876 / 880

页数：5

共 41 条

[1]

Yanagisawa M., Kurihara H., Kimura S., Tombe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332, pp. 411-415, (1988)

[2]

Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T., The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc Natl Acad Sci USA, 86, pp. 2863-2867, (1989)

[3]

Kon V., Badr K.F., Biological actions and pathophysiologic significance of endothelin in the kidney, Kidney Int, 40, pp. 1-12, (1991)

[4]

Sakurai T., Yanagisawa M., Masaki T., Molecular characterization of endothelin receptors, Trends Pharmacol Sci, 13, pp. 103-108, (1992)

[5]

Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S., Cloning and expression of a cDNA encoding an endothelin receptor, Nature, 348, pp. 730-732, (1990)

[6]

Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T., Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor, Nature, 348, pp. 732-735, (1990)

[7]

Hori S., Komatsu Y., Shigemoto R., Mizuno N., Nakanishi S., Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors, Endocrinology, 130, pp. 1885-1895, (1992)

[8]

Pernow J., Boutier J-F, Franco-Cereceda A., Lacroix J.S., Matran R., Lundberg J.M., Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo, Acta Physiol Scand, 134, pp. 573-574, (1988)

[9]

Kinjo T., Takashi M., Miyake K., Nagura H., Phenotypic heterogeneity of vascular endothelial cells in the human kidney, Cell Tissue Res, 256, pp. 27-34, (1989)

[10]

Fant M.E., Nanu L., Word R.A., A potential role for endothelin-1 in human placental growth: interactions with the insulin-like growth factor family of peptides, J Clin Endocrinol Metab, 74, pp. 1158-1163, (1992)

← 1 2 3 4 5 →